Is a complete BNR research report available?

No complete published report is available for Burning Rock Biotech Limited (BNR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · USD

$8.85

+0.03 (+0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BNR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	93.3M
Revenue (ttm)	74.6M
Net income (ttm)	-8.6M
EPS (ttm)	-$0.81
Shares out	10.5M
Volume	2,473
Beta	1.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 74.6M
Net income (ttm): -8.6M
EPS (ttm): -$0.81
Market cap: 93.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BNR indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

CNY

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001792267
Company name	Burning Rock Biotech Limited
Country	China
Country code	US
Cusip	12233L206
Employees	667
Employees Change	-7%
Employees Change Percent	-1.04
Enterprise value	$35.7M
Exchange	NASDAQ
Financial currency	CNY
First seen	2026-05-09
Industry	Diagnostics & Research
Industry PE	44.15
Industry PE Fwd	26.31
IPO Date	2020-06-12
Isin	US12233L2060
Last refreshed	2026-07-31
Market cap	$93.3M
Market cap category	Micro-Cap
Price	$8.85
Price currency	USD
Rev Per Employee	111,818.64x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	8071
Symbol	BNR
Website	https://www.brbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.25%
EV/Sales	0.48x
FCF yield	-6.27%
P/B ratio	1.24x
P/S ratio	1.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-11.37%
EBITDA Margin	-11.37%
Gross margin	74.55%
Gross Profit	$55.6M
Gross Profit Growth	2.52%
Gross Profit Growth Q	-19.91%
Gross Profit Growth3 Y	-0.66%
Gross Profit Growth5 Y	2.08%
Net Income	$-8.6M
Net Income Growth Years	3%
Pretax Margin	-11.23%
Profit Margin	-11.53%
Profit Per Employee	$-12,894
ROA	-4.45
Roa5y	-21.73
ROCE	-10.69
ROE	-10.9
Roe5y	-46.23
ROIC	-6.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	52.37%
Cagr3y	-24.29%
Cagr5y	-48.34%
EPS Growth Years	3
Revenue Growth	-1.69x
Revenue Growth Q	-18.89x
Revenue Growth Years	1x
Revenue Growth3 Y	-3.37x
Revenue Growth5 Y	1.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.63
Assets	$114.2M
Cash	$64.7M
Current Assets	$103.6M
Current Liabilities	$34M
Debt	$7.4M
Debt Equity	$0.1
Equity	$74.9M
Interest Coverage	-1,325.5
Liabilities	$39.3M
Long Term Assets	$10.6M
Long Term Liabilities	$5.4M
Net Cash	$57.3M
Net Cash By Market Cap	$61.59
Net Cash Growth	-12.74%
Net Debt Equity	$-0.77
Tangible Book Value	$74.8M
Tangible Book Value Per Share	$7.11
WACC	10.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.05
Inventory Turnover	2.19
Net Working Capital	$6.7M
Quick ratio	2.71
Working Capital	$68.3M
Working Capital Turnover	$0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.44%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	52.32%
200-day SMA	17.72
3Y total return	-56.62%
50-day SMA	10.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.32%
All Time High	397.5
All Time High Change	-97.77%
All Time High Date	2021-02-22
All Time Low	2.18
All Time Low Change	305.96%
All Time Low Date	2025-05-05
ATR	0.76
Beta	1.33
Beta1y	3.99
Beta2y	1.86
Ch YTD	-56.08
High	9.12
High52	41.72
High52 Date	2026-01-22
High52ch	-78.79%
Low	8.7
Low52	5.31
Low52 Date	2025-08-01
Low52ch	66.64%
Ma50ch	-11.65%
Price vs 200-day SMA	-50.06%
RSI	42.16
RSI Monthly	42.5
RSI Weekly	38.18
Sharpe ratio	0.79x
Sortino ratio	1.32
Total Return	-1.44%
Tr YTD	-56.08
Tr1m	9.53%
Tr1w	-1.12%
Tr3m	-45.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8.5M
Operating margin	-11.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,329,165%
Float Percent	31.57%
Net Borrowing	280,803.4
Shares Insiders	30.92%
Shares Institutions	10.9%
Shares Out	10,546,342
Shares Qo Q	0.41%
Shares Yo Y	1.44%
Short Ratio	1.64
Short Shares	0.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.9M
Adjusted OCF	-7,108,168.4
Average Volume	17,156.5x
Bv Per Share	7.12
CAPEX	$-775,756
Ch1m	9.53
Ch1w	-1.12
Ch1y	52.32
Ch3m	-45.5
Ch3y	-56.62
Ch5y	-96.32
Ch6m	-73.61
Change	0.34%
Change From Open	1.72
Close	8.82
Days Gap	-1.36
Depreciation Amortization	2,096,160.4
Dollar Volume	21,886.1
Earnings Date	2026-09-08
Earnings Time	bmo
EBIT	$-8.6M
EBITDA	$-8.6M
EPS	$-0.81
F Score	4
FCF	$-5.8M
FCF EV Yield	-16.33x
FCF Per Share	$-0.55
Financing CF	275,466
Fiscal Year End	December
Founded	2,014
Income Tax	$226,752
Investing CF	-467,423
Ipr	-46.55
Iprfo	-96.13
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-06-09
Last Report Date	2026-03-31
Last Split Date	2024-05-15
Last Split Type	Reverse
Last10k Filing Date	2026-04-28
Ma150	18.81
Ma150ch	-52.96%
Ma20	9.9
Ma20ch	-10.59%
Net CF	-7,057,152
Next Earnings Date	2026-09-08
Open	8.7
Optionable	No
Position In Range	35.71
Post Close	8.85
Postmarket Change Percent	-1.31
Postmarket Price	$8.73
Ppne	11,664,868.5
Price Date	2026-07-30
Ptbv Ratio	1.24
Relative Volume	0.14x
Revenue	74,583,031x
SBC By Revenue	2.7x
Share Based Comp	2,011,773
Tax By Revenue	0.3x
Tr6m	-73.61%
Volume	2,473
Z Score	-4.35

Burning Rock Biotech Limited (BNR)

Coverage state: Market snapshot only — no published research

Generate the first BNR analysis

Price

Financial snapshot

Fair-value bridge

Latest news · BNR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BNR

Frequently asked questions